The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
Open accessAbstract
OBJECTIVE: Systemic sclerosis (SSc) is a rare and clinically heterogeneous autoimmune disorder characterised by fibrosis and microvascular obliteration of the skin and internal organs. Organ involvement mostly manifests after a variable period of the onset of Raynaud's phenomenon (RP). We aimed to map the incidence and predictors of pulmonary, cardiac, gastrointestinal (GI) and renal involvement in the early course of SSc. METHODS: In the EUSTAR cohort, patients with early SSc were identified as those who had a visit within the first year after RP onset. Incident SSc organ manifestations and their risk factors were assessed using Kaplan-Meier methods and Cox regression analysis. RESULTS: Of the 695 SSc patients who had a baseline visit within 1 year after RP onset, the incident non-RP manifestations (in order of frequency) were: skin sclerosis (75%) GI symptoms (71%), impaired diffusing capacity for monoxide<80% predicted (65%), DU (34%), cardiac involvement (32%), FVC<80% predicted (31%), increased PAPsys>40mmHg (14%), and renal crisis (3%). In the heart, incidence rates were highest for diastolic dysfunction, followed by conduction blocks and pericardial effusion. While the main baseline risk factor for a short timespan to develop FVC impairment was diffuse skin involvement, for PAPsys>40mmHg it was higher patient age. The main risk factors for incident cardiac manifestations were anti-topoisomerase autoantibody positivity and older age. Male sex, anti-RNA-polymerase-III positivity, and older age were risk factors associated with incident renal crisis. CONCLUSION: In SSc patients presenting early after RP onset, approximately half of all incident organ manifestations occur within 2 years and have a simultaneous rather than a sequential onset. These findings have implications for the design of new diagnostic and therapeutic strategies aimed to 'widen' the still very narrow 'window of opportunity'. They may also enable physicians to counsel and manage patients presenting early in the course of SSc more accurately.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849 · cited 2×
“skin involvement (defined as a modifiedRodnan skin score (mRSS) 2 points in at least 1 body area); gastrointestinal (GI) symptoms (defined as the patient reporting either dysphagia, reflux, early satiety, vomiting, diarrhoea, bloating or constipation); a systolic pulmonary artery pressure (PAPsys, as estimated by echo…”
BackgroundPreliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Changes in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Walker, U. A., Tyndall, A., Czirják, L., Denton, C., Farge-Bancel, D., Kowal-Bielecka, O., Müller-Ladner, U., Bocelli-Tyndall, C., & Matucci-Cerinic, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062901 · Cited by 929
Self-citationPrediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
Nihtyanova, S. I., Schreiber, B. E., Ong, V. H., Rosenberg, D., Moinzadeh, P., Coghlan, J. G., Wells, A. U., & Denton, C. P. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38390 · Cited by 460
Meier, F. M. P., Frommer, K. W., Dinser, R., Walker, U. A., Czirjak, L., Denton, C. P., Allanore, Y., Distler, O., Riemekasten, G., Valentini, G., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200742 · Cited by 367
Self-citationSkin thickness and collagen content in progressive systemic sclerosis and localized scleroderma
Rodnan, G. P., Lipinski, E., & Luksick, J. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780220205 · Cited by 341
Mayes, M. D. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00022-x · Cited by 286
Allanore, Y., Meune, C., Vonk, M. C., Airo, P., Hachulla, E., Caramaschi, P., Riemekasten, G., Cozzi, F., Beretta, L., Derk, C. T., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.103382 · Cited by 271
Self-citationPrimary myocardial involvement in systemic sclerosis
Kahan, A., & Allanore, Y. (2006) · Rheumatology · doi:10.1093/rheumatology/kel312 · Cited by 251
Self-citationMinier, T., Guiducci, S., Bellando-Randone, S., Bruni, C., Lepri, G., Czirják, L., Distler, O., Walker, U. A., Fransen, J., Allanore, Y., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203716 · Cited by 226
Self-citationAssassi, S., Sharif, R., Lasky, R. E., McNearney, T. A., Estrada-Y-Martin, R. M., Draeger, H., Nair, D. K., Fritzler, M. J., Reveille, J. D., Arnett, F. C., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3125 · Cited by 180
Nikpour, M., Hissaria, P., Byron, J., Sahhar, J., Micallef, M., Paspaliaris, W., Roddy, J., Nash, P., Sturgess, A., Proudman, S., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3544 · Cited by 164
Kuwana, M., Kaburaki, J., Mimori, T., Tojo, T., & Homma, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116343 · Cited by 161
Perera, A., Fertig, N., Lucas, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22747 · Cited by 157
Is Pulmonary Arterial Hypertension Really a Late Complication of Systemic Sclerosis?
HACHULLA, E., Launay, D., Mouthon, L., Sitbon, O., BEREZNE, A., Guillevin, L., Hatron, P., Simonneau, G., Clerson, P., & Humbert, M. J. C. (2009) · CHEST Journal · doi:10.1378/chest.08-3042 · Cited by 123
Self-citationElhaï, M., Avouac, J., Walker, U. A., Matucci‐Cerinic, M., Riemekasten, G., Airó, P., HACHULLA, E., Valentini, G., Carreira, P. E., Cozzi, F., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206386 · Cited by 109
Self-citationGraf, S. W., Hakendorf, P. H., Lester, S., Patterson, K. A., Walker, J., Smith, M., Ahern, M. J., & Roberts-Thomson, P. J. (2011) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2011.01688.x · Cited by 97
Early- versus Late-Onset Systemic Sclerosis
Alba, M. A., Velasco, C., Simeón‐Aznar, C. P., Fonollosa‐Pla, V., Trapiella, L., Egurbide, M. V., Sáez, L., Castillo, M. J., Callejas-Rubio, J. L., Camps, M. T., et al. (2014) · Medicine · doi:10.1097/md.0000000000000018 · Cited by 78
Omair, M. A., & LEE, P. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110826 · Cited by 70
Late-age Onset Systemic Sclerosis
Manno, R., Wigley, F. M., Gelber, A. C., & Hummers, L. K. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100956 · Cited by 69
Faludi, R., Költô, G., Bartos, B., Csima, G., Czirják, L., & Komócsi, A. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.04.001 · Cited by 53
Valentini, G. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.11.002 · Cited by 37
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Denton, C. P., & Khanna, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30933-9 · Cited by 2,212
Nintedanib for systemic sclerosis–associated interstitial lung disease
Distler, O., Highland, K. B., Gahlemann, M., Azuma, A., Fischer, A., Mayes, M. D., Raghu, G., Sauter, W., Girard, M., Alves, M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903076 · Cited by 1,647
Self-citationFibrosing interstitial lung diseases: knowns and unknowns
Cottin, V., Wollin, L., Fischer, A., Quaresma, M., Stowasser, S., & Harari, S. (2019) · European Respiratory Review · doi:10.1183/16000617.0100-2018 · Cited by 336
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Cottin, V., & Brown, K. K. (2019) · Respiratory Research · doi:10.1186/s12931-019-0980-7 · Cited by 292
The natural history of progressive fibrosing interstitial lung diseases
Kolb, M., & Vašáková, M. (2019) · Respiratory Research · doi:10.1186/s12931-019-1022-1 · Cited by 269
Metadata
- Authors
- Jaeger, V. K., Wirz, E. G., Allanore, Y., Rossbach, P., Riemekasten, G., Hachulla, E., Distler, O., Airò, P., Carreira, P. E., Balbir Gurman, A., Tikly, M., Vettori, S., Damjanov, N., Müller-Ladner, U., Distler, J. H. W., Li, M., Walker, U. A., & co-authors, E.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-10-05
- Volume
- 11
- Issue
- 10
- Pages
- e0163894
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2551533543
- Cited by
- 268
- References
- 25
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.